FDA Fast-Tracks Rasonque Approval for Metastatic Pancreatic Cancer Patients
The FDA granted early approval to Revolution Medicines’ Rasonque, a first-of-its-kind pill that doubled survival rates in clinical trials for patients with metastatic pancreatic adenocarcinoma.
